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Original ArticleHostemicrobiota interaction induces bi-phasic
inﬂammation and glucose intolerance in miceAntonio Molinaro 1, Robert Caesar 1, Louise Mannerås Holm 1, Valentina Tremaroli 1, Patrice D. Cani 2,3,
Fredrik Bäckhed 1,4,*ABSTRACT
Objective: Gut microbiota modulates adiposity and glucose metabolism in humans and mice. Here we investigated how colonization of germ-
free (GF) mice affects kinetics of adiposity and glucose metabolism.
Methods: Adiposity and glucose metabolism were evaluated at different time points in ex-GF and antibiotic treated mice after colonization with
gut microbiota from a conventionally raised (CONV-R) mouse. Mouse physiology, microbiome conﬁguration, serum cytokine levels, and gene
expression for inﬂammatory markers were performed in different tissues.
Results: Colonization resulted in a bi-phasic glucose impairment: the ﬁrst phase occurring within 3 days of colonization (early phase) and the
second 14e28 days after colonization (delayed phase). The early phase co-occurred with an inﬂammatory response and was independent of
adiposity, while the delayed phase was mostly ascribed to adipose tissue expansion and inﬂammation. Importantly, re-colonization of antibiotic
treated mice displays only the delayed phase of glucose impairment and adiposity, suggesting that the early phase may be unique to colonization
of the immature GF mice gut.
Conclusions: Our results provide new insights on hostemicrobiota interaction during colonization of GF mice and the resulting effects on
adiposity and glucose metabolism in a time resolved fashion.
 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Bacterial colonization of the mammalian gut starts at birth [1]. It is a
complex process that undergoes several phases of maturation that
involves several factors and results in the development of the immune
system [1e3]. The gut microbiota has emerged as an important factor
regulating host physiology and metabolism, in particular glucose
metabolism and adiposity [4]. Several studies in humans support the
central role of gut microbiota on adiposity and glucose metabolism,
showing an altered microbiota composition in subjects with obesity
and type 2 diabetes [5e7]. However, the underlying mechanisms are
just starting to be unraveled. The microbial cell membrane component
lipopolysaccharide (LPS) induces low-level inﬂammation and in-
ﬂuences adiposity and glucose tolerance in both mice and humans [8e
10], providing a putative mechanism for the role of microbial-derived
compounds in the development of the metabolic syndrome. Thus,
modulation of gut microbiota and of microbially-produced compounds
in mice and humans has been suggested to improve glucose meta-
bolism, indicating a possible causative role of bacteria in the regulation
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www.molecularmetabolism.comGerm free (GF) mice can be used to study the effect of microbiotae
host interaction on metabolism [15]. GF mice have better glucose
tolerance and lower adiposity than conventionally raised (CONV-R)
mice that are colonized with a normal microbiota at birth [16]. Colo-
nization of GF mice at adulthood with a normal microbiota results in
impairment of glucose metabolism and fat deposition [10,16,17]. In
agreement with these results, ablation of the gut microbiota in CONV-R
mice reduces adiposity and improves glucose metabolism [18,19].
Colonization of GF mice allows studying the kinetics of hostemicro-
biota interaction and provides unique opportunities to investigate the
key events following colonization [15,20]. This model has been used to
study the development of the immune system [20e22] and have
shown that gut microbiota colonization is a rapid and dynamic process,
characterized by the appearance of a low-diversity microbiota around 2
days post-colonization, followed by the succession within 2e3 weeks
of a more complex community resembling the initial inoculum
[20,21,23,24]. Several studies have provided mechanistic evidence for
how the development of a gut microbiota can result into the estab-
lishment of an immune homeostasis promoting the maturation of the
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Original Articlesystem, the development of a gut microbiota also inﬂuences the
regulation of host metabolic genes in the intestine, thus indicating a
possible link between gut microbiota, the immune system, and
metabolism [23].
Although it is known that colonization of GF mice affects glucose
metabolism and adiposity, there is limited knowledge about how the
development of microbiota and its interaction with the host affects
adiposity and glucose metabolism in a time-resolved fashion [10]. Here
we perform a time-resolved study of how microbial colonization of GF
mice affects adiposity and glucose metabolism.
2. MATERIALS AND METHODS
2.1. Mice experiments
GF male Swiss Webster mice, 10e12 weeks old, were maintained in
ﬂexible ﬁlm isolators under a strict 12 h light cycle. GF status was
veriﬁed regularly by anaerobic culturing in addition to PCR for bacterial
16S rRNA gene. All mouse experiments were performed on autoclaved
chow diet (Labdiet) ad libitum.
Colonization and re-colonization experiments were performed in 4 h
fasted mice. The cecum content of an age-, strain-, and sex-matched
mouse was dissolved in 5 ml of buffer (PBS, 0.2 g/L Na2S and 0.5 g/L
cysteine as reducing agents). 200 ml of solution were gavage in 4 h
fasted GF/antibiotic treated mice. For antibiotic treatment, mice were
treated with a combination of 4 different antibiotics in the drinking
water (1 g/L ampicillin, 1 g/L metronidazole, 0.5 g/L vancomycin and
0.5 g/L neomycin, Sigma, St Louis, MO) for 1 week. Antibiotic solution
was changed every 48 h and kept in light protected bottles. Epididymal
white adipose tissue, liver, small intestine, and serum were harvested
4 h after fasting.
2.2. MRI, insulin and cytokines measurement
MRI, insulin, and glucose tolerance tests and measurements of insulin
levels were performed as earlier described [10]. Brieﬂy, insulin and
glucose tolerance tests were performed by injecting insulin (0.75 U/kg
body weight) or glucose (2 g/kg body weight), respectively, intraperi-
toneally after a 4 h fast. Tail blood samples were collected at 0, 15, 30,
60, 90, and 120 min and blood glucose levels were determined using a
glucose meter (Accu Check Aviva, Roche). Insulin and cytokines serum
levels were measured with kits from Meso Scale (Gaithersburg,
Maryland, USA), and Crystal Chem (Downers Grove, Illinois, USA),
respectively, according to the manufacturers’ protocols.
2.3. Immunohistochemistry of EWAT and liver
Parafﬁn-embedded epididymal EWAT and liver sections (7 mm) were
processed as previously described [10]. Brieﬂy, slides were depar-
afﬁnized and processed for antigen retrieval with a 2100 Retriever
using 13 DIVA solution and Hot Rinse (HistoLab Products AB, Goth-
enburg, Sweden). Endogenous peroxidase activity was quenched with
30% H2O2 for 30 min. Blocking in 5% rabbit serum, 1% bovine serum
albumin, and 0.1% Triton X-100 at room temperature for 30 min.
EWAT macrophages were stained with MAC-2/galectin-3 antibody
(diluted 1:500 in blocking buffer overnight at 4 C), and then detected
with a biotinylated anti-rat (10 mg/ml) antibody. Immune complexes
were detected by Vulcan Red reagent (Vector Laboratories, USA), ac-
cording to the manufacturer’s instructions. Crown-like structures were
counted in 15e40 mm2 of histological sections per tissue. For the liver
staining, F4/80 antibody was diluted 1:500 and incubated in blocking
buffer 2 h at room temperature and then detected with a HRP anti-rat
antibody diluted 1:100. Immune complexes were detected by Vec-
tastain ABC kit reagents (Vectorlab, USA) according to the1372 MOLECULAR METABOLISM 6 (2017) 1371e1380  2017 The Authors. Published by Elsemanufacturer’s instructions counterstained with hematoxylin and
quantitated by densitometric analysis using Biopix iQ software (version
2.1.3; Biopix, Sweden). List of antibodies is reported in online
Supplementary Table 3.
2.4. Flow cytometry analysis
Adipose tissue was minced thoroughly and suspended in digestion
solution (PBS, 2% bovine serum albumin, 20 mg collagenase type II,
Sigma Aldrich, St Louis, Missouri, USA). Tissue digestion was per-
formed at 37 C using a shaker at 120 rpm for 40 min. The fat layer
was removed, and cells were passed thought a 70 mm cell strainer.
Cells were centrifuged (500 g, 4 C, 5 min), washed in PBS selection
buffer (PBS, 2 mM EDTA, and 2% BSA), and subsequently treated with
ACK solution (NH4Cl 150 mM, KHCO3 10 mM, and Na2EDTA 0.1 mM)
for 7 min to remove red blood cells. Cells were washed and suspended
in PBS selection buffer with BD Fc Block for 5 min, followed by in-
cubation with antibody cocktails (CD11b/CD11c/Gr1 or CD3/CD4/CD8,
respectively, see Supplementary Table 3 for details). After washing,
cells were analyzed using an Accuri C6 ﬂow cytometer (Accuri
Cytometers, Ann Arbor, Michigan, USA). Data was processed using
FlowJo 10 analysis software (FlowJo LLC, Ashland, Oregon, USA). A
similar protocol was used for spleen and blood samples without the
collagen digestion steps.
2.5. LPS measurement
Blood was collected from the mouse portal vein using a pyrogen free
syringe/needle, and plasma was immediately isolated and frozen in
liquid nitrogen. LPS concentration was measured using Endosafe-MCS
(Charles River, Lyon, France) based on the limulus amoebocyte lysate
(LAL) kinetic chromogenic methodology that measures color intensity
directly related to the endotoxin concentration in a sample. Plasma was
diluted with endotoxin-free buffer to minimize interferences in the
reaction (inhibition or enhancement) and heated for 15 min at 70 C.
Each sample was diluted with endotoxin-free LAL reagent water
(Charles River) and treated in duplicate, and two spikes for each
sample were included in the determination [25].
2.6. Quantitative RT-PCR
Quantitative RT-PCR RNA was isolated using RNeasy kit with on-
column DNase treatment (Qiagen, Hilden, Germany). cDNA templates
were synthesized from total RNAs using the high-capacity cDNA
reverse transcription kit (Applied Biosystems, Foster City, California,
USA) according to the manufacturer’s instructions. qRT-PCR assays
were performed in 10 ml reactions containing 8 ml SYBR Green Master
Mix buffer (Thermo Scientiﬁc, Waltham, Massachusetts, USA), and 2 ml
of 900 nM gene-speciﬁc primers (300 nM primer concentrations were
used to assess L32 transcripts). Gene expression data were normal-
ized to the ribosomal protein L32. Primer sequences are reported in
online Supplementary Table 4.
2.7. Liver lipid analysis
Snap frozen liver tissues were homogenized in 1.5 ml Chloroform/
methanol (2:1 v/v). Lipids were measured using Inﬁnity Triglycerides
kit (Thermo Fischer Scientiﬁc).
2.8. Extraction of fecal genomic DNA and proﬁling of the fecal
microbiota
Fresh fecal pellets for extraction of fecal genomic DNA were collected
from 5 mice after 1, 3, 7, 14, and 28 days of colonization. Total fecal
genomic DNA was extracted from one fecal pellet using a repeated
bead beating method based on a protocol previously described [26].vier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Brieﬂy, fecal pellets were placed in Lysing Matrix E tubes (MP Bio-
medicals) and extracted twice in lysis buffer (4% w/v SDS; 500 mmol/L
NaCl; 50 mmol/L EDTA; 50 mmol/L Tris$HCl; pH 8) with bead beating
at 5.0 m/s for 60 s in a FastPrep-24 Instrument (MP Biomedicals).
After each bead-beating cycle, samples were heated at 85 C for
15 min and then centrifuged at full speed for 5 min at 4 C. Super-
natants from the two extractions were pooled and the DNA was ﬁrst
precipitated with isopropanol and then puriﬁed using the QIAamp DNA
Mini kit (QIAGEN). Samples were eluted in 120 mL of AE buffer
(10 mmol/L Tris$Cl; 0.5 mmol/L EDTA; pH 9.0).
The fecal microbiota was proﬁled by sequencing the V4 region of the
16S rRNA gene on an Illumina MiSeq instrument (Illumina RTA
v1.17.28; MCS v2.5) with 515F and 806R primers designed for dual
indexing [27] and the V2 Illumina kit (2  250 bp paired-end reads).
16S rRNA genes were ampliﬁed in duplicate reactions in volumes of
25 ml containing 1 Five Prime Hot Master Mix (5 PRIME GmbH),
200 nM of each primer, 0.4 mg/ml BSA, 5% DMSO, and 20 ng of total
fecal genomic DNA. PCR was carried out under the following condi-
tions: initial denaturation for 3 min at 94 C, followed by 25 cycles of
denaturation for 45 s at 94 C, annealing for 60 s at 52 C, and
elongation for 90 s at 72 C, and a ﬁnal elongation step for 10 min at
72 C. Duplicates were combined, puriﬁed with the NucleoSpin Gel
and PCR Clean-up kit (MachereyeNagel), and quantiﬁed using the
Quant-iT PicoGreen dsDNA kit (Invitrogen). Puriﬁed PCR products were
diluted to 10 ng/ml and pooled in equal amounts. The pooled amplicons
were puriﬁed again using Ampure magnetic puriﬁcation beads
(Agencourt) to remove short ampliﬁcation products.
Illumina reads were merged using PEAR and quality ﬁltered by
removing all reads that had at least one base with a q-score lower than
20 [28]. Quality ﬁltered reads were analyzed with the software
package QIIME (version 1.9.1) [29]. Sequences were clustered into
operational taxonomic units (OTUs) at a 97% identity threshold using
an open-reference OTU picking approach with UCLUST [30] against the
Greengenes reference database [31] (13_8 release). All sequences
that failed to cluster when tested against the Greengenes database
were used as input for picking OTUs de novo. Representative se-
quences for the OTUs were Greengenes reference sequences or
cluster seeds and were taxonomically assigned using the Greengenes
taxonomy and the Ribosomal Database Project Classiﬁer [32].
Representative OTUs were aligned using PyNAST [33] and used to
build a phylogenetic tree with FastTree [34], which was used to
calculate a- and b-diversity of samples using Phylogenetic Diversity
[35] and UniFrac [36]. Three-dimensional principal coordinates anal-
ysis plots were visualized using Emperor [37]. Chimeric sequences
were identiﬁed with ChimeraSlayer [38] and excluded from all
downstream analyses. Similarly, OTUs that could not be aligned with
PyNAST, singletons and low abundant OTUs with a relative abundance
<0.001% were also excluded. We obtained an average of
68,095.4  13,092.3 sequences/sample (mean  SD; range
44,539e96,244 sequences/sample); a total of 1,838,576 sequences
and 794 OTUs were included in the analyses. To correct for differences
in sequencing depth between samples, 44,539 sequences were
randomly sub-sampled from each sample and included in the analyses
for the estimation of a- and b-diversity.
Sequence data are available at the European Nucleotide Archive (ENA)
with accession number PRJEB21676.
2.9. Statistical analysis
Data are presented as mean  SEM. Analyses between groups were
determined by one-way analysis of variance with ad hoc BonferroniMOLECULAR METABOLISM 6 (2017) 1371e1380  2017 The Authors. Published by Elsevier GmbH. This is
www.molecularmetabolism.compost tests using GraphPad Prism 7 software. See speciﬁc ﬁgure leg-
ends for more details.
Differences in alpha and beta diversity were tested with the Kruskale
Wallis and Friedman tests adjusted for multiple comparisons. p-Values
below 0.05 were considered statistically signiﬁcant. Clustering of
samples by BrayeCurtis and weighted UniFrac distances according to
time of sampling and mouse identiﬁcation number was tested using
the adonis function in QIIME with 999 permutations. Wald test with
paired design implemented in DESeq2 was used for the analysis of
differential abundance of OTUs present in 50% of the samples (in 13
out of the 25 fecal samples) and grouped at genus level [39].
3. RESULTS AND DISCUSSION
3.1. Colonization of GF mice produces bi-phasic glucose
intolerance
Several studies using colonization of GF mice have focused on
medium-long term effect of microbiota colonization (14e28 days, up
to 12e15 weeks) on host adiposity and glucose metabolism [40e42].
Here we evaluated the effect of microbiotaehost interaction on
adiposity and glucose metabolism during a period of 28 days after
colonization using Swiss Webster mice as a model of mild obesity on
chow diet in order to study the effect of microbiota on metabolism in
obesity to avoid the pro-inﬂammatory effect of high fat diets [43].
We colonized adult GF mice (conventionalized mice; CONV-D) by oral
gavage with cecum content of age- and sex-matched CONV-R mice
and analyzed adiposity and glucose metabolism at ﬁve different time-
points of colonization (1, 3, 7, 14, and 28 days). Body weight was
transiently reduced 7 days after colonization (Figure 1A). The reduction
in body weight was associated with reduced cecum weight after
colonization (Supplementary Figure 1A), a hallmark of the conven-
tionalization process [16]. After 14e28 days of colonization, we
observed weight gain (Figure 1A) associated with increased adiposity
(Figure 1B), epididymal fat pad (EWAT) weight (Figure 1C), and
increased adipocyte size (Figure 1D and E). These ﬁndings are likely
secondary to microbiota-induced increase of energy harvesting from
diet after colonization in the host [16].
Next, we investigated how glucose metabolism was affected during
the establishment of the gut microbiota community. Interestingly, we
observed two separate phases of increased fasting glucose levels
(Figure 1F). A ﬁrst phase was observed within the ﬁrst 3 days after
colonization (early phase), after which, around 7 days post coloniza-
tion, the levels of fasting glucose decreased and returned to those
observed in GF mice. Interestingly, we observed a second phase at 14
and 28 days post colonization (delayed phase), coinciding with the
increased adiposity and in agreement with previous studies [10,16].
Insulin levels and HOMA score were signiﬁcantly increased by colo-
nization in the delayed phase, but not in the early phase (Figure 1G,
Supplementary Figure 1B). In order to characterize glucose metabolism
during colonization in more detail, we performed glucose tolerance
tests (GTT) at each time point. Similar to fasting glucose levels, we
found that glucose tolerance was impaired during the early phase and
the delayed phase compared to GF mice, with the most pronounced
attenuation observed 1 day post-colonization and normalization of
glucose tolerance similar to GF mice levels around 7 days post colo-
nization (Figure 1H and I). A similar trend was observed when we
evaluated insulin levels during GTT (Supplementary Figure 1C). Similar
results were observed when insulin tolerance tests (ITT) were per-
formed in a separate cohort of CONV-D, GF, and CONV-R mice
(Supplementary Figure 1D and E). Our ﬁndings show that microbiotaan open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 1373
Figure 1: Colonization of GF mice induces a bi-phasic impairment of glucose metabolism. Body weight (A), body fat mass percentage (B), and relative epididymal white
adipose tissue (EWAT) weight (C) in germ-free (GF), conventionalized (CONV-D), and conventionally raised (CONV-R) mice, 10e15 mice per group. Representative hematoxylin and
eosin staining of EWAT (D) (scale bars 100 mm) and mean adipocyte size (E) in GF, CONV-D, and CONV-R mice, 4e10 mice per group. Glucose (F) and insulin (G) levels in GF,
CONV-D, and CONV-R mice, 10e15 mice per group. Glucose levels (H) and glucose area under the curve (AUC) (I) during intraperitoneal glucose tolerance in GF, CONV-D, and
CONV-R mice, 10e15 mice per group. Data are plotted as mean  SEM. *p < 0.05, **p < 0.01, ***p < 0.001, One-Way ANOVA each group vs GF mice. See also Supplementary
Figure 1.
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impairs host glucose metabolism in a bi-phasic time dependent
fashion during colonization of CONV-D mice. Since the maximum
impairment in glucose tolerance was observed at day 1 post coloni-
zation, in the absence of signiﬁcant increase in insulin we propose that
this is mediated by dramatic insulin resistance. This is also observed
during infections and thus may be attributed to the dramatic load of
bacteria and inﬂammatory molecules [44e46]. In contrast, the delayed
phase of glucose impairment is associated with increased adiposity, in
agreement with previous publication [10].
3.2. Colonization of GF mice is characterized by a bi-phasic
systemic inﬂammatory response
Inﬂammation is known to affect glucose metabolism, and bacterially
produced LPS is one of the mediator of this process [9,47]. Thus, we
evaluated the effect of microbiota colonization on LPS and cytokines
serum levels.
In portal blood, we observed a consistent trend towards increased LPS
levels in CONV-D mice with a peak at 1 day post colonization
(Figure 2A), co-occurring with dramatic impairment of GTT. The
increased levels of bacteria-derived inﬂammatory molecules in the
portal vein is likely the result of colonization of an immature gut with
impaired barrier function and was mirrored by elevated levels of
increased serum levels of pro-inﬂammatory cytokines, such as IL-6,
INFg, IL-12, and TNFa (Figure 2B). IL-6 and IFNg reached theirA
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TNFa showed a bi-phasic ﬂuctuation with a ﬁrst peak of increment in
the early phase- and a later one in the delayed phase. On the other
hand, IL-4, which has anti-inﬂammatory effect promoting the alter-
native activation of macrophages [48], was transiently increased at
time-point 1 day compared to GF mice, while the levels of the anti-
inﬂammatory cytokine IL-10 were slightly increased to a rather con-
stant level from day 3 onwards (Figure 2B). No differences in serum
levels of IL-1b, KC/GRO, and Il-5 during colonization. The increased
levels of several cytokines in the early phase could be responsible per
se for the early phase of glucose impairment and be consequent to the
acute microbiotaehost interaction, while the increased levels in the
delayed phase (i.e. TNF alpha, IL-10, and IL-12) can be secondary to
the continuous exposure to the microbial components such as LPS
(Figure 2A) [49]. These results are consistent with previous published
data [22,50] on colonization of GF, in which cytokine production
peaked four days after colonization.
To further characterize the inﬂammatory response during colonization,
we performed ﬂow cytometry analysis of the circulating and spleen-
resident T-cells. In CONV-D mice, colonization induced a transient
reduction of the CD4/CD8 ratio indicating a systemic inﬂammatory
response during the early phase (Figure 2C and D). Taken together, our
data indicate that colonization of GF mice results in a systemic in-
ﬂammatory response, during colonization process. A transient glucoseD
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Original Articletolerance impairment and increased cytokine release is observed
during the ﬁrst three days of life in humans, associated with coloni-
zation of the gut [51e53].
3.3. Colonization of GF mice is characterized by a bi-phasic
inﬂammatory response in liver and adipose tissue
Next, we aimed to identify which metabolic tissues (i.e., liver and
adipose tissue) were involved in the inﬂammatory response. We found
that the inﬂammatory response in the early phase mainly affects the
liver, as shown by the immunostaining for F4/80, a marker of mac-
rophages, which revealed a transient recruitment of these cells during
the early phase of colonization (Figure 3A and B). This ﬁnding was also
supported by the qRT-PCR analysis on Emr1, the gene encoding for F4/
80 protein in mice (Figure 3C). qPCR-RT analysis also showed an
increased hepatic expression of some pro- (Saa3, Il6) and anti- (Il10,
Mgl1) inﬂammatory markers only in the early phase e ﬁrst week post
colonization (Figure 3C). The elevated levels of SAA3, which is an acute
phase protein, may be a protective response to the increased inﬂux of
microbial products (such as LPS). Colonization did not affect liver
weight (data not shown) or liver triglycerides (Supplementary Figure 2).
In EWAT, we immunostained for the macrophage marker MAC-2 to
visualize crown-like structures, representing accumulation of mac-
rophages around dead adipocytes, a marker of adipose tissue
inﬂammation associated with impaired glucose metabolism in obesity
[54]. We were not able to visualize any signiﬁcant increase of crown-
like structures in the early phase whereas an increased accumulation
was evident in the delayed phase (Figure 3D and E). Moreover, ﬂow
cytometry analysis in EWAT for resident pro-inﬂammatory macro-
phages (CD11cþGr/CD11bþ cells) showed an increased number of
these cells only in the delayed phase (28 days) of colonization
(Figure 3F). qRT-PCR analysis of EWAT for the pan-macrophage
marker Emr1 showed an increased expression in CONV-R
compared to GF mice but only a trend towards increased expres-
sion in CONV-D mice (Figure 3G). When we analyzed the expression in
the EWAT of CONV-D mice of several pro- (Tnfa, Il6, Saa3) and anti-
inﬂammatory (Mgl1 and Il10) markers, only Saa3 and IL-10 showed
signiﬁcantly increased expression in the early phase (3 days) of
colonization. These ﬁndings indicate that recruitment of inﬂammatory
cells to EWAT occurs in the delayed phase of colonization, while the
expression of inﬂammatory markers starts already in early phase of
colonization. These data are in line with our ﬁndings that adiposity is
increased 14e28 days after colonization during the delayed phase of
glucose intolerance (Figure 1BeE). Thus, the impaired glucose
metabolism we observed in the delayed phase of colonization of GF
could be mainly due to the increased whole-body adiposity, adipose
tissue inﬂammation, and adipocyte size. These data are in line with
our previous study showing an increased expression of markers for
both pro- and anti-inﬂammatory macrophages in EWAT after coloni-
zation of GF mice [10].
Interestingly, despite being the site of a direct contact between the host
and the microbiota, the intestine did not show an increased inﬂam-
matory response in the early phase of colonization. We did not observe
any changes in intestinal gene expression for Emr1 during colonization.
Pro- and anti-inﬂammatory markers such as Tnfa, Il6, Il10, and Mgl1
were up regulated only after 7e28 days of colonization, while the pro-
inﬂammatory marker Saa3 showed a single peak of expression only
after 7 days of colonization (Supplementary Figure 3). These ﬁndings
are consistent with our previous results showing that the microbiotae
host interaction needs at least one week to induce the expression of
genes involved in the immune response towards bacteria in the in-
testine [55].1376 MOLECULAR METABOLISM 6 (2017) 1371e1380  2017 The Authors. Published by ElseTaken together these results indicate that microbiotaehost immune
system interaction modulates inﬂammation in different organs in
different phases of the colonization process. Speciﬁcally, colonization
of the naïve GF gut allows inﬂux of pro-inﬂammatory molecules leading
to an acute inﬂammation with elevated levels of cytokines and pro-
duction of acute phase proteins, predominantly affecting the liver in the
early phase of colonization. In contrast, the delayed phase is likely a
result of increased energy harvest from the diet resulting in increased
adiposity in particular due to adipose tissue expansion leading to
impaired glucose tolerance. However, we cannot exclude the impact of
additional microbially regulated factors such as gastric emptying,
vagus nerve tone, and GLP-1 secretion and action [56,57].
3.4. Establishment of a gut microbiota in adult GF mice
To clarify how the microbiota is affected during colonization of GF mice
we determined the composition of the fecal microbiota at the same
time points as for the measurements of adiposity and glucose meta-
bolism (1, 3, 7, 14 and 28 days in CONV-D mice) using 16S rRNA gene
proﬁling. Species diversity was estimated by the number of observed
operational taxonomic units (OTUs; observed species) as well as
phylogenetic diversity (PD). We observed that species diversity
increased rapidly after colonization and reached a maximum after 28
days (Supplementary Figure 4A and B).
We then used weighted UniFrac and BrayeCurtis indexes to follow the
changes in overall microbiota composition at operational taxonomic
unit (OTU) level. Principal coordinates analysis (PCoA) showed strong
clustering by day of sampling (Supplementary Figure 4C and D; adonis
for weighted UniFrac: p ¼ 0.001, r2 ¼ 0.69; adonis for BrayeCurtis:
p¼ 0.001, r2¼ 0.75), and revealed that fecal communities were more
similar within time points than within individual mice (adonis analysis
showed no clustering by mouse identiﬁcation number; adonis for
weighted UniFrac: p ¼ 0.225, r2 ¼ 0.06; adonis for BrayeCurtis:
p ¼ 0.376, r2 ¼ 0.04). PCoA analysis also showed that the fecal
microbiota became increasingly more similar to the inoculated cecal
microbiota used to colonize the mice (Supplementary Figure 3E and F),
and, in agreement with these results, we found that the number of
OTUs shared between fecal samples and the inoculum increased with
time, with a successful colonization of about 82% of the inoculated
cecal taxa by day 28 (Supplementary Figure 4G and H).
We also investigated the speciﬁc changes in relative abundance of
microbial genera during colonization and observed signiﬁcant differ-
ences for 30 out of the 35 genera detected in the fecal samples
(Supplementary Table 1 and Supplementary Figure 4I), showing that
major rearrangements of the fecal microbiota took place at each time
point.
Taken together, proﬁling of the fecal microbiota during colonization of
GF mice showed that both species richness and overall microbiota
composition changed rapidly during the ﬁrst week of colonization. As
we observed strong clustering of fecal samples by day of sampling, we
conclude that speciﬁc interactions between colonizing species and gut
environment take place at each time point, leading to the selection of a
similar gut microbiota in the different mice. We speculate that the
activation of speciﬁc immune responses and/or the establishment of
new intestinal conditions at the different time points might be
responsible for the selection of the microbiota, as also previously
shown [20,22].
3.5. Re-colonization of antibiotic treated mice is characterized only
by a delayed phase of glucose impairment
It is noteworthy that GF mice have an immature immune system due to
the lack of interaction with bacterial antigens [58]. Thus, thevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 3: Colonization of GF mice induces increased inﬂammatory response in the liver during the early phase in the liver and in the EWAT during the delayed phase.
Representative ﬁgures (A) and quantiﬁcation of F4/80 positive area (B) in the liver, (scale bars 100 mm) in in germ-free (GF), conventionalized (CONV-D) and conventionally raised
(CONV-R) mice, 4e10 mice per group. C. Relative mRNA expression in the liver for Emr1, Saa3, TNFa, Il6, Il10, and Mgl1 in GF, CONV-D, and CONV-R mice, 5e10 mice per group.
Representative ﬁgures (D) and quantiﬁcation (E) of EWAT crown-like structure positive area (scale bars 100 mm), in GF, CONV-D, and CONV-R mice, 4e10 mice per group. Red
arrows indicate crow-like structures. F. CD11cþ, Gr1, CD11bþ EWAT resident macrophages, determined by ﬂow cytometry in GF, CONV-D, and CONV-R mice, 4e7 mice per
group. G. Relative mRNA expression in the EWAT for Emr1, Saa3, TNFa, Il6Il10, and Mgl1 in GF, CONV-D, and CONV-R mice, 5e10 mice per group. Data are plotted as
mean  SEM. *p < 0.05, **p < 0.01, ***p < 0.001 One-Way ANOVA each group vs GF mice. See also Supplementary Figure 2.
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Figure 4: Colonization of conventionally re-derived mice (CONV-RD) do not induce an early phase of glucose impairment. Body weight (A) and body fat mass percentage
(B) in antibiotic treated mice (Abx), conventionally re-derived (CONV-RD) and conventionally raised (CONV-R) mice, 5e13 mice per group. Fasting glucose (C) and insulin (D) levels
in Abx, CONV-RD, and CONV-R mice, 5e13 mice per group. Glucose levels (E) and glucose area under the curve (AUC) (F) during intraperitoneal glucose tolerance in Abx, CONV-RD
and CONV-R mice, 5e13 mice per group. Data are plotted as mean  SEM. */zp < 0.05, zzp < 0.01, ***/zzz, zOne way ANOVA each group vs Abx mice, *One way ANOVA each
group vs CONV-R mice.
Original Articleinﬂammatory response that we observed in the early phase could be
ascribed to a GF mice immature immune system [58,59]. In order to
investigate how the interaction between microbiota and a normal
immune system affects glucose metabolism during colonization, we
used CONV-R mice treated with antibiotics for 1 week (Abx mice),
which result in mice with a mature immune system and intact gut
integrity, but dramatically reduced levels of bacteria. We evaluated
adiposity and glucose metabolism before and 1, 3, 7, 14, and 28 days
after re-colonization. We referred these mice as conventional re-
derived (CONV-RD).
As shown before [18,19], antibiotic treatment reduced body weight
and body fat, which was fully recovered 28 days after re-colonization
(Figure 4A and B). CONV-RD mice did not show an early phase of
impaired fasting glucose levels upon re-colonization, while fasting
glucose gradually reached CONV-R mice levels over time (Figure 4C).
Insulin levels showed a peak of increase one day after re-colonization
(Figure 4D) but did not affect fasting glucose levels. GTT and HOMA
showed that CONV-RD mice had a delayed phase of glucose impair-
ment but not an early phase of glucose impairment (Figure 4E and F,
Supplementary Figure 5A and B). Our results suggest a central role of
the immune system in the host metabolic control in the early stage of
the microbiota colonization process and that the early phase of
impaired glucose metabolism may be related to the immature gut of GF
mice.
Importantly, colonization of GF and Abx mice resulted in a similar in-
crease in adiposity (Figures 1B and 4B) after 28 days, suggesting that
this is not related to gut integrity or immune system maturation.1378 MOLECULAR METABOLISM 6 (2017) 1371e1380  2017 The Authors. Published by Else4. CONCLUSIONS
In conclusion, our data reveal that the establishment of the microbial
community biphasically modulates glucose tolerance in mice. The
early phase is likely due to an immature gut, and absent in antibiotic
treated CONV-R mice, with resulting increase in intestinal permeability
of pro-inﬂammatory molecules leading to impaired glucose tolerance.
The increase in hepatic inﬂammation may be a result of detoxiﬁcation
of pro-inﬂammatory molecules such as LPS [60]. The delayed phase is
induced by increased adiposity, due mainly to increased adiposity and
EWAT expansion and inﬂammation and thus of relevance for type 2
diabetes.
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